Literature DB >> 1527262

A comparison of continuous positive pressure ventilation, combined high frequency ventilation and airway pressure release ventilation on experimental lung injury.

I Jousela1, K Linko, A Mäkeläinen.   

Abstract

In pigs with oleic induced lung injury, the effectiveness of combined high frequency ventilation (CHFV, with VDR-Phasitron) and airway pressure release ventilation (APRV) were compared to continuous positive pressure ventilation (CPPV) in a randomized study. The respiratory rate was 15/min, CPAP 8 mmHg and FiO2 0.25. PaCO2 was maintained at 5 kPa. PaO2 was significantly lower with APRV (12.5 +/- 3.9 kPa, CPPV: 15.8 +/- 3.9 kPa, and CHFV: 15.5 +/- 3.2 kPa). This was in accordance with the lowest peak airway pressure during APRV (20.9 +/- 4.8 mmHg, CPPV: 26.3 +/- 4.4 mmHg and CHFV: 28.2 +/- 3.7 mmHg). There was no difference in the pericardiac pressure between the 3 ventilation modes. The pressure related depressive effects on the cardiovascular function during CHFV and APRV were similar to those during CPPV. Adequate oxygenation and ventilation could be achieved with both CHFV and APRV, but these methods were not superior to CPPV.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527262     DOI: 10.1007/bf01706479

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  14 in total

1.  Hemodynamic effects of positive end-expiratory pressure during high-frequency ventilation.

Authors:  M S Mikhail; M J Banner; T J Gallagher
Journal:  Crit Care Med       Date:  1985-09       Impact factor: 7.598

2.  Airway pressure release ventilation.

Authors:  M C Stock; J B Downs; D A Frolicher
Journal:  Crit Care Med       Date:  1987-05       Impact factor: 7.598

3.  Airway pressure release ventilation: a new concept in ventilatory support.

Authors:  J B Downs; M C Stock
Journal:  Crit Care Med       Date:  1987-05       Impact factor: 7.598

4.  Continuous positive airway pressure and supplemental oxygen in the treatment of cardiogenic pulmonary edema.

Authors:  I T Väisänen; J Räsänen
Journal:  Chest       Date:  1987-09       Impact factor: 9.410

5.  Cardiovascular effects of conventional positive pressure ventilation and airway pressure release ventilation.

Authors:  J Räsänen; J B Downs; M C Stock
Journal:  Chest       Date:  1988-05       Impact factor: 9.410

6.  Ventilatory strategy in catastrophic lung disease. Inversed ratio ventilation (IRV) and combined high frequency ventilation (CHFV).

Authors:  J B Andersen
Journal:  Acta Anaesthesiol Scand Suppl       Date:  1989

7.  Effects of oleic acid-induced pulmonary edema on lung mechanics.

Authors:  R F Grossman; J G Jones; J F Murray
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1980-06

8.  Mean airway pressure vs. positive end-expiratory pressure during mechanical ventilation.

Authors:  A Pesenti; R Marcolin; P Prato; M Borelli; A Riboni; L Gattinoni
Journal:  Crit Care Med       Date:  1985-01       Impact factor: 7.598

9.  Effects of positive end-expiratory pressure on cardiac output distribution in the pig.

Authors:  E Haldén; S Jakobson; L Janerås; K Norlén
Journal:  Acta Anaesthesiol Scand       Date:  1982-08       Impact factor: 2.105

10.  Sequential cardiopulmonary changes after oleic-acid injury in dogs.

Authors:  W F Hofman; I C Ehrhart; W M Granger; D A Miller
Journal:  Crit Care Med       Date:  1985-01       Impact factor: 7.598

View more
  2 in total

Review 1.  Airway pressure release ventilation and biphasic positive airway pressure: a systematic review of definitional criteria.

Authors:  Louise Rose; Martyn Hawkins
Journal:  Intensive Care Med       Date:  2008-07-17       Impact factor: 17.440

Review 2.  Partial ventilatory support modalities in acute lung injury and acute respiratory distress syndrome-a systematic review.

Authors:  Sarah M McMullen; Maureen Meade; Louise Rose; Karen Burns; Sangeeta Mehta; Robert Doyle; Dietrich Henzler
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.